
|Articles|October 15, 2014
- Gastrointestinal Cancers (Issue 3)
- Volume 3
- Issue 1
Immunotherapy and Viral Therapy for Pancreatic Cancer
Tanios Bekaii-Saab, MD, discusses the future of immunotherapy and viral therapy for the treatment of pancreatic cancer.
Advertisement
Articles in this issue
about 11 years ago
Unanswered Questions Regarding the Treatment of Pancreatic NETsabout 11 years ago
Targeted Agents and Combinations Being Studied in Pancreatic NETsabout 11 years ago
Sequencing Agents for the Treatment of Pancreatic NETsabout 11 years ago
Research on Epidemiology of GIST Identifies Risk Factorsabout 11 years ago
Antiangiogenic Strategies for mCRC Need Further Explorationabout 11 years ago
Coping With Comorbidities in Hepatocellular Cancerabout 11 years ago
Strategies in Surveillance: Hepatocellular CarcinomaAdvertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































